Politics

Oregon psilocybin emails show secret data collection plans

I received a batch of emails from the Oregon Health Authority (OHA) in response to a public records request… sheds light on the secretive OPEN Project (the Oregon Psilocybin Evaluation Nexus), which aims to collect detailed information on the psychedelic experiences of all psilocybin clients in Oregon. Emails show that Todd Korthuis, M.D., M.P.H. plans…

READ MORE
Biography/Memoir

…psychedelic surge

“I am an advocate for psychedelics. I can’t help it,” explains 57-year-old Jacqueline Lopez, “I mean, it wasn’t that long ago that I thought to myself, ‘What are you thinking, Jackie? These are Schedule I drugs. You can’t just go around talking about them.’ But the science behind it is superb and I had seen…

READ MORE
Psychology

Can psychedelics follow cannabis’ lead?

The psychedelics industry is similar to where the cannabis industry was 10 years ago as it fights for legalization in various countries. Retail establishments in the Netherlands that specializes in the sale of psychoactive substances, such as magic truffles, are called Smart Shops. There are an estimated 100 Smart Shops operating in the Netherlands, generating…

READ MORE
Biography/Memoir

All veterans should have access to the psilocybin…

Even the Department of Veterans Affairs (VA) has started offering psychedelic substances to patients as a part of clinical trials. Veteran Luke Gruber said, “I didn’t want the pills provided by the Department of Veterans Affairs. And talk therapy just didn’t help. Rudderless and prone to extreme mood swings, I increasingly isolated myself from family…

READ MORE
Biography/Memoir

Patent controversies in psychedelics

The competition for patents is well under way… each company has interpreted the decision as a win, with Freedom to Operate saying the decision limits Compass Pathways’ “ownership [to] . . . the exact shape of their form of psilocybin, and not others,” while Compass Pathways does not “see how avoiding infringing on their patents…

READ MORE
Politics

…suggests psilocybin for terminally ill patients has financial interest…

As part of their efforts to better understand DEA’s administrative process, Aggarwal [Washington State, Seattle] and his counsel have submitted several Freedom of Information Act (FOIA) requests for relevant documents. DEA’s FOIA policy states that it will consider waiving or reducing fees if the requester is shows that the information is “in the public interest because…

READ MORE
Science

…Awareness… the implementation of medical cannabis and psychedelics… adjunct to standard therapy… advanced metastatic…

Published in the Journal, Drug Science, Policy and Law, [with authors Rayyan Zafar and David Nutt (who performed the first MRI of a human brain under the influence of LSD)], from Imperial College London, Centre for Psychedelic Research and Neuropsychopharmacology, UK: this case highlights the plausible therapeutic role of such plant-based medicines in oncology treatment…

READ MORE